Background and Aims. To test prospective associations between cannabis disorder
Introduction
Cannabis is the most widely used illicit drug worldwide, and young adulthood is a period of active cannabis use (1, 2) . Numerous studies have underlined the detrimental effects of cannabis use on health, including neuropsychological and cognitive impairment (3) (4) (5) (6) , and mental health problems (7) (8) (9) (10) (11) . However, although neuropsychological impairment has been studied through causal pathways (3, 12) , debate continues about the causal association of cannabis use and mental health problems, and the incidence of psychiatric disorders and schizophrenia that result from repeated cannabis use in teenage years and young adulthood (11, (13) (14) (15) (16) (17) (18) .
Moreover, there is also a debate about which measure of cannabis use should be taken into account: does cannabis dependence alone lead to mental health problems, or are frequent cannabis users (i.e. not necessarily dependent cannabis users) also affected by an increase in detrimental health issues? Frequency of use refers to cannabis use, which may be used in a nonproblematic way, without any negative consequences. Cannabis dependence is a substance-use disorder, which implies frequent (daily) use and negative effects on users' live. Some studies have reported that both frequency of cannabis use and cannabis dependence are linked to mental health problems (11, (18) (19) (20) (21) , but others have pointed out that frequent cannabis use is not associated with increased internalising disorders such as depression (19, 22, 23) . This study aimed to fill in these gaps, by testing causal pathways from frequency of cannabis use and cannabis dependence to mental health issues (mental health problems, depression). Additional health issues were added to investigate the consequences of cannabis use in young adulthood more precisely (e.g. physical health problems and health consequences).
Investigating trajectories of cannabis use in early adulthood was an additional aim. Several studies have shown that cannabis use is stable during late adolescence and early adulthood (24) (25) (26) (27) (28) . About 80% of young adults remain in the same category of use (cannabis use/non-use). For example, Schulenberg et al (24), Arrial et al. (26) and Brook et al. (27) reported 80%, 87.2% and 81.4% of continuity in cannabis use/non-use, respectively. However, the focus of these studies was rarely to investigate trajectories themselves because the initiation of cannabis use has often already occurred by the late teenage years or early twenties (29, 30) . They focused rather on identifying protective factors or risk factors surrounding increased cannabis use and the detrimental consequences of that use. Indeed, this interesting result of cannabis use stability across late adolescence and early adulthood has not yet been highlighted.
Thus, this study's aims were twofold: 1) to investigate cannabis use trajectories and find out whether the patterns of cannabis use among young adults were stable or transient; 2) to test prospective pathways between symptoms of cannabis use disorder/frequency of cannabis use and health issues (mental health issues and more general health issues).
Method

Participants and procedures
The data presented here were collected in the Cohort Study on Substance Use Risk Factors (C-SURF), a longitudinal study designed to assess substance use patterns and their related consequences in young Swiss men. Participants were enrolled in three of Switzerland's six army recruitment centres. These three centres cover 21 of the country's 26 cantons (including all French-speaking ones) and are located in Lausanne (French-speaking), Windisch and Mels (German-speaking). There is no pre-selection for this conscription, and all young men around 20 years-old are evaluated to determine their eligibility for military, civil or no service because army recruitment is obligatory in Switzerland. Thus, all young Swiss men around 20 years-old were eligible for study inclusion. The recruitment centers were only used to enroll participants.
Assessment of baseline and follow-up data was carried out outside the army environment and independently of eligibility for military service. Participants who gave a written consent to participate in recruitment centers were invited two weeks later by mail or email to fill in a paper and pen or an online questionnaire, according to the favorite way they indicated in the written consent. For follow-up, all the participants were similarly invited to fill in the questionnaire, by mail or email. A previous study about sampling and non-response bias can be found in Studer et al. (31) . As this study reported that non-response bias was small in the sample and because missing values were less than 5%, listwise deletion was preferred to multiple-imputation which can introduce bias in statistical inference. participants how many times they had used cannabis during the past 12 months. Answers were collected on a 5-point scale coded 1 for 'monthly or less', 2 for '2-4 times a month', 3 for '2-3 times a week', 4 for '4-5 times a week', and 5 for 'every day or almost every day'.
Cannabis disorder symptoms. At Times 1 and 2, participants were asked about symptoms of cannabis use disorder during the past 12 months using the Cannabis Use Disorder Identification Test, CUDIT (32) . This is a ten-item assessment tool for evaluating cannabis misuse (abuse and dependence); it is scored 0 (no misuse) to 40 (misuse). A continuous score was used to better capture variability among cannabis users.
Depression. The Major Depressive Inventory (ICD-10)-WHO-MDI was used at Times 1 and 2
to assess levels of depression (33, 34) . This is a ten-item questionnaire that screens answers on a six-point scale from 0 (never) to 5 (all the time). A continuous scale (ranging from 0 to 50) was used instead of a cut-off, to better capture variability across the range of symptoms for depression and the severity of depression states. The total scale score of MDI has been previously described as a sufficient statistic (33) .
Mental and physical health. Physical and mental health were assessed at Times 1 and 2 using the Short Form Health Survey (SF-12) (35), with two subscales: the mental component summary (dealing with mental and social health), and physical component summary (dealing with physical health). These subscales were calculated according to their standard scoring, giving 2 composite scores ranging from 0 (health problem) to 100 (no health problem). The mental component summary primarily covered sadness, nervousness and depression.
Health consequences. At Times 1 and 2, seven health consequences were selected from standard instruments (36-39). These were not explicitly substance related as the use of substanceattributed consequences introduces bias (40) . They included accident/injury, admittance to an emergency department, attempted suicide, need for medical treatment, overnight stay in hospital, outpatient surgery, and treatment of an accident/injury in an emergency department. Each consequence was coded 0 if it had not occurred in the past 12 months and 1 if it had occurred at least once during the past 12 months. A mean score was then calculated.
Statistical analyses
Two series of analyses investigated the two aims of the study: investigating cannabis use trajectories and testing the causal pathways between cannabis use and health issues.
1) Cannabis use trajectories
First, descriptive statistics for the whole sample (N=5,084) were calculated to investigate patterns of cannabis use at Times 1 and 2. Associations of cannabis use (cannabis disorder symptoms, frequency of cannabis use) with health-related outcomes were tested with Spearman correlations.
Then, significant changes in cannabis use across time were tested using the t-test for paired samples for number of cannabis disorder symptoms and the related-samples Wilcoxon signed rank test for frequency of cannabis use. These analyses involved cannabis users and not noncannabis users (N=1,939) including participants who used cannabis at Time 1 and/or Time 2, with measurements on cannabis use were settled at zero (cannabis disorder symptoms and frequency of cannabis use) for those who had not used cannabis in the 12 months prior to Times 1 or 2.
2) Longitudinal pathways between cannabis use and health issues
To provide evidence regarding the direction of the relationship between cannabis use and health issues, cross-lagged panel models were used. These models indicate predominant causal influences and allow an examination of whether one variable predict subsequent changes in the other variable, and of the reserve lagged associations. The 'causal winner' (41) is the variable that predicts the other without being predicted itself in return.
Two models were tested: one for the cannabis disorder symptoms, and the other for frequency of cannabis use. Models included a) autoregression (i.e. the regression between the same variable at These two models were tested for all cannabis users, and then only for the subgroup of continuing cannabis users. As the results were very similar (the only difference was that the path coefficients were a little higher for continuing cannabis users), only the models including all cannabis users are presented. Cross-lagged panel models were tested controlling for age of first cannabis use and language (French-and German-speaking); the model for cannabis disorder symptoms was tested controlling for frequency of cannabis use. Cross-lagged panel models were carried out using Mplus 6 (42); other analyses used SPSS 21.
Insert Figure 1 about here
Results
Cannabis use trajectories
At Time 1, participants were 19.98 ± 1.19 years old. Descriptive statistics are shown in Table 2 .
Most of the participants (84.5%) remained in the same use category and only 15.5% changed their cannabis use between Times 1 and Time 2.
Insert Table 2 about here Associations between cannabis use and health issues are shown in Table 3 for all cannabis users and continuing cannabis users. Significant but low correlations (|r| < .30) are displayed for most outcomes. Both synchronous and longitudinal associations seemed higher for cannabis disorder symptoms rather than frequency of cannabis use. No clear longitudinal pathway between cannabis use and health issues appeared.
Insert Table 3 being late onset users and 7.2% being matured out users.
The stability of patterns of cannabis use was investigated among all cannabis users and continuing cannabis users (i.e. participants who used cannabis 12 months prior to both Times 1 and 2). The results showed that these users had stable patterns of cannabis use, as their number of cannabis disorder symptoms and frequency of cannabis use were similar across time. Previous studies showed that cannabis use was stable among young adults because initiation had occurred earlier (29, 30) , and the present study highlighted that patterns of cannabis use were also stable across time in the studied sample. It seemed that patterns of cannabis use had already been established at this age in this population. This result may be useful for preventive purposes, as it reveals that interventions aimed against an initiation to cannabis and against cannabis use patterns should occur during teenage years, at least among young males in their early twenties.
Longitudinal pathways between cannabis use and health issues were then tested. The results
showed that cannabis disorder symptoms should be considered as a predictor of health issues, but that frequency of cannabis use should not, in line with the conclusions of studies reporting that frequency of cannabis use was not related to health issues (19, 22, 23). Indeed, cross-lagged panel models showed a causal path between cannabis disorder symptoms and health issues (depression, mental health, physical health, health consequences), but not reversed causal paths between health issues and cannabis disorder symptoms. It is interesting to see that the cannabis disorder symptoms lead to health issues despite its substantial continuity across time. Even a stable (i.e. not increasing) number of cannabis disorder symptoms may lead to poorer health outcomes. On the other hand, frequency of cannabis use did not predict health issues and so did not appear as a cause of deteriorated health. One can suspect that users reporting many cannabis disorder symptoms are also heavy cannabis users, but the frequency of cannabis use was controlled for in the cross-lagged model for cannabis disorder symptoms. Thereby, the number of cannabis disorder symptoms seems not only to reflect the magnitude of use, but also something different in the style or type of use.
This study had some limitations. The main one was that it did not include women. More studies are needed to see whether these patterns and causal pathways also fit women's substance use behaviour. Another shortcoming was that the frequency of cannabis use was assessed using an ordinal scale. Further investigations with continuous scales are needed to more accurately capture the variability between cannabis users and patterns of use. A third limitation was the use of the number of cannabis disorder symptoms, which is not strictly speaking an assessment of cannabis dependence, even if it does give an overview of both cannabis abuse and dependence.
Moreover, even if cross-lagged models allow the assessment of possible causal associations, they cannot prove causality (43) . Evaluating causal relationships is especially hard when substance use is at focus, as individuals vulnerable to psychiatric disease may use more psychoactive substances than normal. Finally, data used in this study were self-reported. Although selfreported data on risky behaviors and substance use are generally considered valid (44) , it could introduce various forms of bias including recall bias, pressure to give desirable answers and non-response bias. Self-rating for health issues, especially for depression and mental health assessment also did not allow knowing the factual clinical state of the participants. More investigations with external diagnosis are needed. However, SF12 and MDI are documented as reliable and validated measures of mental health status, with high responsiveness, sensitivity, empirical validity and associations with presence and seriousness of mental condition (33, 35) .
For all these reasons, the results of this study should be interpreted cautiously and conclusions about causal pathways between health issues and cannabis use need more investigations, including external diagnosis for health-related outcomes and cannabis use.
In conclusion, the substantive contributions of this study are twofold. First, cannabis use patterns (prevalence rates and changes in use, number of cannabis disorder symptoms and frequency of cannabis use) showed substantial continuity among young Swiss males in their early twenties.
Although results for prevalence rates had been shown in previous studies, to our knowledge, none of them had underlined this phenomenon. This study also highlighted that not only were prevalence rates of cannabis use stable across time, but so were the ways in which continuing users used cannabis-at least for males at this young age of around 20 years old. Therefore, Frequency of cannabis use equal zero was used as the reference category.
*** p < .001.
Standardized β are given.
